China's Fosun, Shanghai Pharma circle Georgia drugmaker Arbor for U.S. beef-up
admin 14th August 2017 Uncategorised 0Fosun Pharma and Shanghai Pharma, the two Chinese companies previously rumored to be eyeing generics maker Stada, are back on the M&A radar. And rather than publicly denying their deal interest this time, the two have confirmed offers for U.S. drugmaker Arbor Pharma.
More: China's Fosun, Shanghai Pharma circle Georgia drugmaker Arbor for U.S. beef-up
Source: fierce